Day case total hip arthroplasty is associated with excellent functional outcomes, patient satisfaction and net promoter score: One-year outcomes for the first 50 patients using the Fife Protocol
Article Sidebar
Main Article Content
Abstract
Introduction
The primary aim of this study was to assess outcomes after day case THA using the Fife protocol. Secondary aims were to assess (1) improvements in health-related quality of life, (2) factors associated with outcomes, (3) patient satisfaction, and (4) postoperative complications.
Methods
A prospective study of 50 patients undergoing day case THA was undertaken. Patient demographics, pre and postoperative (1-year) outcomes [Oxford hip score (OHS) and EuroQol 5-dimensional 3-level (EQ-5D)] were assessed. Perioperative complications, readmissions and patient satisfaction at one-year were recorded. The study was powered to the OHS.
Results
33 male and 17 female patients, mean age 62 (41 to 76), mean BMI of 27.7 (18 to 37). The majority were ASA grade II (n=38). There were significant improvements in the OHS (24.1, 95% CI 21.9 to 26.4, p<0.001) and EQ-5D (0.414, 95% CI 0.332 to 0.495, p<0.001). Regression modelling identified that preoperative OHS and EQ-5D were independently associated with one-year postoperative change in OHS (p<0.001) and EQ-5D (p<0.001) respectively. All patients were satisfied (n=3) or very satisfied (n=47). Five patients stated they were "likely" and 45 stated they were "extremely likely" to go through surgery again. All were "likely" (n=4) or "extremely likely" (n=46) to recommend surgery to friends or family, with a Net Promoter Score® of 92%. No complications were reported at mean 26 month follow up.
Conclusions
Day case THA was associated with improvement in hip-specific and health related quality of life at one-year. Day case THA has an exceptional Net Promotor Score.
Downloads
Article Details
References
Litwic A, Edwards MH, Dennison EM, Cooper C. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013 Mar;105(1):185–99.
Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: Estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(7):1323–30.
Hall AJ, Dunstan E. Day-case total hip arthroplasty: a safe and sustainable approach to improve satisfaction and productivity, and meet the needs of the orthopaedic population. Orthop Trauma. 2022 Feb 1;36(1):14–21.
Ackerman IN, Bohensky MA, Zomer E, Tacey M, Gorelik A, Brand CA, et al. The projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030. BMC Musculoskelet Disord. 2019 Feb 23;20(1):1–10.
NHS England. Statistical Press Notice NHS referral to treatment (RTT) waiting times data December 2021. 2022.
Adrian Sayers; Kevin Deere; Erik Lenguerrand; Setor K Kunutsor; Jonathan L Rees; Andy Judge; Yoav Ben-Shlomo; Celia L Gregson; Emma M Clark; Mike Reed; Timothy Wilton; Derek J Pegg. The COVID-19 induced joint replacement deficit in England, Wales and Northern Ireland [Internet]. The National Joint Registry 18th Annual Report 2021. 2021 [cited 2022 Feb 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK576854/?report=reader
Bhanu Mishra, Michael Shenouda, P. Julian Owen, BODS Collaborators BR. BODS/BOA Survey of impact of COVID-19 on UK orthopaedic practice and implications on restoration of elective services [Internet]. British Orthopaedic Association. 2020 [cited 2022 Feb 23]. Available from: https://www.boa.ac.uk/resources/bods-boa-survey-of-impact-of-covid-19-on-uk-orthopaedic-practice-and-implications-on-restoration-of-elective-services.html
Pabinger C, Lothaller H, Portner N, Geissler A. Projections of hip arthroplasty in OECD countries up to 2050. HIP Int. 2018 Sep 1;28(5):498–506.
Culliford D, Maskell J, Judge A, Cooper C, Prieto-Alhambra D, Arden NK. Future projections of total hip and knee arthroplasty in the UK: Results from the UK Clinical Practice Research Datalink. Osteoarthr Cartil. 2015 Apr 1;23(4):594–600.
Oussedik S, Zagra L, Shin GY, D’Apolito R, Haddad FS. Reinstating elective orthopaedic surgery in the age of COVID-19. Bone Joint J. 2020 Jul 1;102-B(7):807–10.
DeCook CA. Outpatient Joint Arthroplasty: Transitioning to the Ambulatory Surgery Center. J Arthroplasty. 2019 Jul 1;34(7S):S48–50.
Wainwright TW. The current status of daycase hip and knee arthroplasty within the English National Health Service: a retrospective analysis of hospital episode statistics data. Ann R Coll Surg Engl. 2021 May 1;103(5).
Centre for Perioperative Care and British Association of Day Surgery. Getting it Right First Time (GIRFT) National Day Surgery Delivery Pack. 2020.
Thompson JW, Wignadasan W, Ibrahim M, Beasley L, Konan S, Plastow R, et al. Day-case total hip arthroplasty: a literature review and development of a hospital pathway. https://doi.org/101302/2633-146222BJO-2020-0170R1. 2021 Feb 12;2(2):93–102.
Dey S, Gadde R, Sobti A, Macdonald N, Jacob J, Unnithan A. The safety and efficacy of day-case total joint arthroplasty. Ann R Coll Surg Engl. 2021 Oct 1;103(9):638–44.
Sam Jain, Sarah Paice, Mike Reed PP. Is day case hip and knee replacement surgery achievable in the NHS? J Trauma Orthop. 2019;7(4).
Lovasz G, Aros A, Toth F, Va Faye J, La Malfa M. Introduction of day case hip and knee replacement programme at an inpatient ward is safe and may expedite shortening of hospital stays of traditional arthroplasties. J Orthop Surg Res. 2021 Dec 1;16(1):1–7.
Saunders P, Smith N, Syed F, Selvaraj T, Waite J, Young S, et al. Introducing a day-case arthroplasty pathway significantly reduces overall length of stay. https://doi.org/101302/2633-1462211BJO-2021-0106R1. 2021 Nov 3;2(11):900–8.
Hamilton DF, Lane J V., Gaston P, Patton JT, MacDonald D, Simpson AHRW, et al. What determines patient satisfaction with surgery? A prospective cohort study of 4709 patients following total joint replacement. BMJ Open. 2013 Jan 1;3(4):e002525.
Chow A, Mayer EK, Darzi AW, Athanasiou T. Patient-reported outcome measures: The importance of patient satisfaction in surgery. Surgery. 2009 Sep 1;146(3):435–43.
Aasvang EK, Luna IE, Kehlet H. Challenges in postdischarge function and recovery: the case of fast-track hip and knee arthroplasty. Br J Anaesth. 2015 Dec 1;115(6):861–6.
Kehlet H, Thienpont E. Fast-track knee arthroplasty -- status and future challenges. Knee. 2013 Sep;20 Suppl 1(SUPPL.1).
Dawson J, Fitzpatrick R, Carr A, Murray D. QUESTIONNAIRE ON THE PERCEPTIONS OF PATIENTS ABOUT TOTAL HIP REPLACEMENT. https://doi.org/101302/0301-620X78B20780185. 1996 Mar 1;78(2):185–90.
Brooks R, De Charro F. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72.
Beard DJ, Harris K, Dawson J, Doll H, Murray DW, Carr AJ, et al. Meaningful changes for the Oxford hip and knee scores after joint replacement surgery. J Clin Epidemiol. 2015 Jan 1;68(1):73–9.
Yeo MGH, Goh GS, Chen JY, Lo NN, Yeo SJ, Liow MHL. Are Oxford Hip Score and Western Ontario and McMaster Universities Osteoarthritis Index Useful Predictors of Clinical Meaningful Improvement and Satisfaction After Total Hip Arthroplasty? J Arthroplasty. 2020 Sep 1;35(9):2458–64.
Larsen K, Hansen TB, Søballe K. Hip arthroplasty patients benefit from accelerated perioperative care and rehabilitation: a quasi-experimental study of 98 patients. Acta Orthop. 2008;79(5):624–30.
Hamilton DF, Lane J V., Gaston P, Patton JT, MacDonald DJ, Simpson AHRW, et al. Assessing treatment outcomes using a single question: The Net Promoter Score. Bone Jt J. 2014 May 1;96 B(5):622–8.
Frederick F Reichheld. The one number you need to grow - PubMed. Harv Bus Rev. 2003;81(12):46–54.
Stirling P, Jenkins PJ, Clement ND, Duckworth AD, McEachan JE. The Net Promoter Scores with Friends and Family Test after four hand surgery procedures. J Hand Surg Eur Vol. 2019 Mar 1;44(3):290–5.
Customer Guru. NET PROMOTER SCORE BENCHMARKS FOR TOP BRANDSNo Title [Internet]. [cited 2022 Mar 22]. Available from: https://customer.guru/net-promoter-score/top-brands
Ferguson RJ, Palmer AJ, Taylor A, Porter ML, Malchau H, Glyn-Jones S. Hip replacement. Lancet. 2018 Nov 3;392(10158):1662–71.
Crawford RW, Murray DW. Total hip replacement: indications for surgery and risk factors for failure. Ann Rheum Dis. 1997 Aug 1;56(8):455–7.
Liang MH, Cullen KE, Larson MG, Thompson MS, Schwartz JA, Fossel AH, et al. Cost-effectiveness of total joint arthroplasty in osteoarthritis. Arthritis Rheum. 1986;29(8):937–43.
Jenkins PJ, Clement ND, Hamilton DF, Gaston P, Patton JT, Howie CR. Predicting the cost-effectiveness of total hip and knee replacement: a health economic analysis. Bone Joint J. 2013 Jan;95-B(1):115–21.
Maempel JF, Clement ND, Ballantyne JA, Dunstan E. Enhanced recovery programmes after total hip arthroplasty can result in reduced length of hospital stay without compromising functional outcome. Bone Jt J. 2016 Apr 1;98B(4):475–82.
Jones EL, Wainwright TW, Foster JD, Smith JRA, Middleton RG, Francis NK. A systematic review of patient reported outcomes and patient experience in enhanced recovery after orthopaedic surgery. Ann R Coll Surg Engl. 2014 Mar 11;96(2):89–94.
Wainwright TW, Gill M, McDonald DA, Middleton RG, Reed M, Sahota O, et al. Consensus statement for perioperative care in total hip replacement and total knee replacement surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations. New Pub Med Journals Sweden. 2019 Jan 2;91(1):3–19.
Rosinsky PJ, Chen SL, Yelton MJ, Lall AC, Maldonado DR, Shapira J, et al. Outpatient vs. inpatient hip arthroplasty: a matched case-control study on a 90-day complication rate and 2-year patient-reported outcomes. J Orthop Surg Res. 2020 Aug 31;15(1).
Aynardi M, Post Z, Ong A, Orozco F, Sukin DC. Outpatient surgery as a means of cost reduction in total hip arthroplasty: a case-control study. HSS J. 2014 Oct 1;10(3):252–5.
Burn E, Edwards CJ, Murray DW, Silman A, Cooper C, Arden NK, et al. Trends and determinants of length of stay and hospital reimbursement following knee and hip replacement: evidence from linked primary care and NHS hospital records from 1997 to 2014. BMJ Open. 2018 Jan 1;8(1):e019146.
NHS. Consultation on 2021/22 National Tariff Payment System Annex DtC: Guidance on best practice tariffs. 2021.